Navigation Links
Handheld device for detecting counterfeit and substandard medicines tested by PQM
Date:2/20/2013

Rockville, Md., February 13, 2013 With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines. The device, called TruScan, is currently used to test Active Pharmaceutical Ingredients (API) and finished pharmaceutical products, and it was evaluated for its ability to differentiate among drug products with different APIs, different brands of the same API, and drug products having the same API but of different strengths, with focus on the specificity and precision of the testing. While TruScan could be used successfully in the initial screening for authentication of the identity of certain targeted medicines, it may not be reliable enough to establish whether the medicines are substandard or not. The print version of the study appears in the journal's February issue.

"Thin Layer Chromatography (TLC) test methods, such as Minilab, which PQM uses on a regular basis to detect counterfeit and substandard medicines, have been in the market for several years. They are quite reliable, but require specific training and the use of chemicals," said Mustapha Hajjou, Ph.D., lead author of the study, and a program manager for USP's Promoting the Quality of Medicines program (PQM), which is funded by USAID. "There is an increased interest in other, 'non-invasive' spectroscopic methods to detect counterfeit medicines, including near-infrared (NIR) and Raman spectroscopy, like the device we tested, and those would undoubtedly be simpler to use. We just have to make sure they produce reliable results for various types of medicines including substandard medicines, and that is what we tried to evaluate with the TruScan device," he explained. USP is a scientific, nonprofit public health organization that sets standards for the quality of medicines, food ingredients and dietary supplements. USP standards are used in more than 140 countries.

Antimalarial medicines artesunate and combination sulfadoxine-pyrimethamine (SP) were used in the evaluation because of their common use and the prevalence of counterfeit and substandard products in markets where malaria is endemic, and because of previous unfavorable reports of testing these products with a Raman device. Ibuprofen and acetyl salicylic acid tablets were also used, due to their wide range of products with different strengthsallowing the scientists to study the device's ability to discriminate between these products. A reference spectrum or signature, reference standard or a formulation (whole tablet) was created first to be compared to the spectra of other samples. Samples testing yielded either a match or fail result.

Results for the evaluation of antimalarials showed that the device's precision depend on the nature and strength of the active pharmaceutical ingredient (API). All medicines tested obtained acceptable precision results although, for some products, the results were well below 100 percent. The low matching results were attributed to high fluorescence masking the Raman signal, which could generate false negative results in authenticating medicines.

In the specificity evaluation, the Raman device successfully differentiated APIs, which would be useful in testing counterfeit finished products containing the wrong API. However, in the comparison with different lots of the same product and the comparison with similar products from different manufacturers, some samples did not match themselves, and the SP samples from four different manufacturers matched the comparator, showing the device is not sufficient to discriminate among these samples.

The device was also evaluated for its ability to detect different strengths of the same API. Acetyl salicylic acid and acetaminophen tablets all matched the comparator product, regardless of the sample strength, showing the device's limitation in possibly detecting substandard medicines from these classes of drugs.

"We concluded that TruScan will likely detect counterfeit medicines that lack API or have the wrong API, but we cannot rely on it to detect substandard medicines. This is especially true in the case of fixed-dose combinations, where one API may have a strong Raman scatter, masking the signal for other APIs. Because most of the effective medicines treating malaria, HIV/AIDS, and tuberculosis are fixed-dose combinations, we need to be very cautious in using this device for assessment of substandard medicines, says Patrick Lukulay, Ph.D., vice president of USP's Global Health Impact Programs and program director for PQM.


'/>"/>

Contact: Claudia Costabile
cac@usp.org
301-816-8314
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
2. In Rat Study, Eye Device Shows Promise for Restoring Sight
3. Biochip-based device for cell analysis
4. New device warns workers of high levels of airborne metals in minutes rather than weeks
5. Device implanted in brain has therapeutic potential for Huntingtons disease
6. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
7. Oakworks Medical, a Division of Oakworks Inc., Oakworks.com, Manufacturer of Medical Tables and Positioning Devices Announces ISO 13485 Certification
8. Device is effective in managing incontinence after surgery
9. Adena Delivers Instant Health Information to Mobile Devices
10. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
11. Popularity Causing Several Week Lag In Delivery Of 'Plug In' Device To Start Saving On Electricity Between 8% and 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: